The Life Sciences Virtual Investor Forum, co-hosted by Zacks Small-Cap Research and B2i Digital, will take place over two days on June 24 and 25, 2026. The forum features more than 20 public companies spanning clinical-stage biotechnology, rare-disease and oncology therapeutics, molecular diagnostics, medical devices, veterinary medicine, nutrition science, and AI-powered digital health. Each company will have 30 minutes for a live presentation followed by real-time Q&A, with one-on-one meeting requests available through the Virtual Investor Conferences (VIC) platform. Replays will be accessible on B2i Digital and OTC Markets YouTube channels.
B2i Digital, as the Official Marketing Partner, brings the forum into its ecosystem, leveraging a distribution and media engine that drives qualified investors to presentations and meetings. The company amplifies the event across its platform, reaching a proprietary network of more than 1.7 million retail and institutional market participants. This visibility engine has supported over 115 investor conferences. Zacks Small-Cap Research, a preferred provider in the OTC Markets Group's Research Marketplace, prepares independent company-sponsored research and related content, with its team of life sciences analysts co-hosting the forum.
David Shapiro, Chief Executive Officer of B2i Digital, stated: "Life sciences investors want efficient, direct access to management teams developing the therapies and technologies that matter, and pairing that access with independent research from Zacks makes the forum more valuable on both sides. Over two days, investors can meet companies across biotech, diagnostics, devices, and digital health, and reach their own conclusions."
The presenting companies as of June 17, 2026, include Protalix BioTherapeutics, MetaVia Inc., CytoSorbents Corporation, PetVivo Holdings, Jaguar Health, Reviva Pharmaceuticals, 4DMedical, Prostatype Genomics, Abingdon Health, Innovotech, Lakewood-Amedex Biotherapeutics, Nasus Pharma, Kelyniam Global, IMUNON, Promino Nutritional Sciences, Envoy Medical, Coiled Therapeutics, Aspire Biopharma Holdings, Rocket Doctor AI, Phio Pharmaceuticals, aTyr Pharma, and NuFarm. The schedule is subject to change.
To request one-on-one meetings with management, visit the registration page. For more details and company profiles, see B2i Digital's forum page. Registration is available at Virtual Investor Conferences.
Throughout the year, Virtual Investor Conferences feature public companies from exchanges worldwide, including NYSE, Nasdaq, TSX, TSXV, CSE, ASX, LSE, and OTC Markets. Virtual Investor Conferences is a property of OTC Markets Group Inc.
